Coming Soon

Opening Plenary and Introduction to IPVC

Tuesday, March 24 | 17:30 – 19:15 | Room 115

  • Welcome by the meeting co-chair – Silvia De Sanjose, USA (PATH, Director of Scale-up Project Reproductive Health Global Program)
  • Welcome by the IPVS President and meeting co-chair – Margaret Stanley, UK (University of Cambridge, Department of Pathology, Emeritus Professor of Epithelial Biology)
  • Frontiers in modern Oncology in Spain – lecture by Luis Paz-Ares, Spain (Hospital Universitario Doce de Octubre, Medical Oncology department, Chief Physician)
  • Immunology – lecture by Rafi Ahmed, USA (Emory Vaccine Center, Director)



IPVC Plenary Session 2

Wednesday, March 25 | 08:00 – 09:30 | Room 115

  • Global control of Hepatitis B – Pierre Van Damme, Belgium (University of Antwerp, Faculty of Medicine and Health Sciences, Professor)
  • HPV Pathogenesis in Animal Models – Paul Lambert, USA (Carbone Cancer Center, Director of the McArdle Laboratory for Cancer Research, Virology Program Leader)
  • Immunotherapy: Progress in the clinic – Cornelis Melief, The Netherlands (ISA Pharmaceuticals, Chief Scientific Officer; Leiden University Medical Center, Emeritus Professor and Head of the Department of Immunohematology and Blood Transfusion)



IPVC Plenary Session 3

Thursday, March 26 | 08:30 – 10:00 | Room 115

  • T cell dysfunction and implications for immunotherapy – Andrea Schietinger, USA (Memorial Sloan Kettering Cancer Center, Assistant Professor and Cancer Immunologist)
  • Potential use of Nanoparticle therapy in HPV associated cancers and the potential role for precancer treatment – Howard Gendelman, USA (Durham Research Center, Professor of Internal Medicine and Infectious Diseases)
  • Methylation – Martin Widschwendter, UK (University College London, Head of the Department of Women’s Cancer)



IPVC Plenary Session 4

Friday, March 27 | 09:30 – 11:00 | Room 115

  • Resource-appropriate immunotherapeutic approaches to the elimination of cervical cancer – Corey Casper, USA (Infectious Disease Research Institute, Interim President and Chief Scientific Officer)
  • Use of Deep Learning into Cervical Cancer Screening – Mark Schiffman, USA (National Cancer Institute, Senior Investigator)
  • Oral Cancer Therapeutics – Robert Ferris, USA (UPMC Hillman Cancer Center, Director)



IPVC Closing Plenary

Friday, March 27 | 15:30 – 17:00 | Room 112

  • Immunology HPV vaccines – Denise Galloway, USA (Fred Hutch; Pathogen-Associated Malignancies Integrated Research Center, Scientific Director)
  • WHO’s Cervical Cancer Elimination Strategy – Princess Nothemba Simelela, Switzerland (Assistant Director-General/Special Adviser to DG, Strategic Programmatic Priorities)
  • Video message from WHO Director-General Tedros Adhanom Ghebreyesus
  • HPV, a personal view – Xavier Bosch, Spain (Catalan Institute of Oncology (ICO), Honorary Consultant to the Cancer Epidemiology Research Program & Director of the e-oncologia at ICO)
  • IPVC 2021 – Ann Burchell, Canada (Dept of Family and Community Medicine and MAP Centre for Urban Health Solutions, St Michael’s Hospital, Associate Professor) & Eduardo Franco, Canada (Department of Oncology, McGill University, Professor and Chair)